The Tryptophan System in Cocaine-Induced Depression
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. Thi...
Main Authors: | Francina Fonseca, Joan-Ignasi Mestre-Pintó, Àlex Gómez-Gómez, Diana Martinez-Sanvisens, Rocío Rodríguez-Minguela, Esther Papaseit, Clara Pérez-Mañá, Klaus Langohr, Olga Valverde, Óscar J. Pozo, Magí Farré, Marta Torrens, on behalf of NEURODEP GROUP |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/4103 |
Similar Items
-
A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor)
by: Benjamin Keller, et al.
Published: (2017-12-01) -
The Uniqueness of Tryptophan in Biology: Properties, Metabolism, Interactions and Localization in Proteins
by: Sailen Barik
Published: (2020-11-01) -
Tryptophan and Substance Abuse: Mechanisms and Impact
by: Majid Davidson, et al.
Published: (2023-02-01) -
Tryptophan metabolites in depression: Modulation by gut microbiota
by: Iva Lukić, et al.
Published: (2022-09-01) -
Dysregulation of the Tryptophan Pathway Evidences Gender Differences in COPD
by: Shama Naz, et al.
Published: (2019-10-01)